Clinical study to evaluate efficacy of Kamalanashakyoga in Bahupitta Kamala w.s.r to Unconjugated Jaundice
Phase 2
- Conditions
- Health Condition 1: K769- Liver disease, unspecifiedHealth Condition 2: K769- Liver disease, unspecified
- Registration Number
- CTRI/2022/09/045282
- Lead Sponsor
- Dr Mamta Kadam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subject will be included irrespective of gender,religion, economical status, Occupation education etc
2.Subject having complains of Peeta varnata, Daurbalya, Avipaka, Daha, Aruchi, Angsaad
3.Subjects in the age group of 16 to 60 years
4.Subject having serum bilirubin level more than 1 mg/d
Exclusion Criteria
1.pregnancy
2.kamala with updrava and Kamala occuring as an updrava in other diseases
3.Cirrhosis of liver
4.Obstructive jaundice
5.Chronic hepatitis
6.subjects having serum bilirubin level more than 10 mg /dL
7.Patients with serum bilirubin level less than 1 mg/d
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in symptoms <br/ ><br>1.peetavarnata of netra,mutra,mala,twaka <br/ ><br>2.Daurbalya <br/ ><br>3.Avipak <br/ ><br>4.Daha <br/ ><br>5.Aruchi <br/ ><br>6.AngasadTimepoint: 15 days
- Secondary Outcome Measures
Name Time Method Decreased serum bilirubinTimepoint: 30 days